SHCC MU NCORP

描述 3 总体审查标准和影响 3 融资机会公告（FOA）特定标准 9 组织和结构 9 临床试验研究 10 癌症护理交付研究 11 运营/数据管理 12 其他审查标准 14 人类受试者注意事项 14 妇女、少数民族和儿童的融入 14 任何额外的评审考虑 14 资源共享 14 预算和支助期 14 特别强调小组名册 描述（由申请人提供）：John H.位于伊利诺伊州芝加哥的库克县小斯特罗杰医院（SHCC）是库克县卫生和医院系统（CCHHS）的主要三级护理站点。大多数癌症病例来自少数群体，主要是非洲裔美国人。SHCC计划通过实施NCI社区肿瘤学研究计划（NCORP）来发展，加强和改善协调的护理和临床研究。托马斯E. Lad将继续担任主要研究者（PI）。SHCC NCORP将保持和培养与MBCCOP计划下形成的癌症研究基地的关系，以促进广泛和更好地参与乳腺癌、肺癌、前列腺癌、胃癌、脑癌、血液癌、头颈癌和妇科癌症的治疗和预防/控制试验;通过发起和主持ECOG小组范围内的癌症控制，增加研究基础水平的科学活动/CCDR关于女性癌症患者生殖问题的研究;增加对肿瘤学家和其他癌症相关医疗保健提供者的支持;鼓励多学科癌症护理和综合研究;通过参与NCI，促进将最先进的高质量肿瘤护理和新技术转移给自己社区中服务不足的少数群体，批准的临床试验;专注于预防和控制，作为降低癌症发病率，发病率和死亡率的方法;通过访问芝加哥地区以患者为中心的结果研究网络，扩大我们的临床试验菜单，包括癌症护理提供研究（CAPriCORN）数据库，该数据库由太平洋地区气候变化研究所的一大笔赠款支持;扩大和促进研究的参与和机会，重点是服务社区的特殊需要，促进外展和教育。

DESCRIPTION 3 OVERALL REVIEW CRITERIA AND IMPACT 3 FUNDING OPPORTUNITY ANNOUNCEMENT (FOA) SPECIFIC CRITERA 9 ORGANIZATION AND STRUCTURE 9 CLINICAL TRIALS RESEARCH PROGRAM 10 CANCER CARE DELIVERY RESEARCH PROGRAM 11 OPERATIONS/DATA MANAGEMENT 12 ADDITIONAL REVIEW CRITERIA 14 PROTECTIONS FOR HUMAN SUBJECTS 14 INCLUSION OF WOMEN, MINORITIES, AND CHILDREN 14 ADDITIONAL REVIEW CONSIDERATIONS 14 RESOURCE SHARING PLAN 14 BUDGET AND PERIOD OF SUPPORT 14 SPECIAL EMPHASIS PANEL ROSTER DESCRIPTION (provided by applicant): John H. Stroger Jr, Hospital of Cook County (SHCC) in Chicago, Illinois is the major tertiary care site for the Cook County Health and Hospital System (CCHHS). The majority of cancer cases are from minority-underserved populations, and are predominantly African American. SHCC plans to develop, strengthen and improve coordinated care and clinical research through the implementation of the NCI Community Oncology Research Program (NCORP). Dr. Thomas E. Lad will continue as Principal Investigator (PI). The SHCC NCORP will maintain and nurture relationships with cancer research bases formed under the MBCCOP program to facilitate broad and improved participation in treatment and prevention/control trials for breast, lung, prostate, gastrointestinl, brain, hematologic, head and neck, and gynecologic cancers; increase scientific activity at the research base level by initiating and chairing an ECOG group-wide cancer control/CCDR study concerning reproductive issues of female cancer patients; increase support for oncologists and other cancer related healthcare providers; encourage multidisciplinary cancer care and integrated research; facilitate transfer of state-of-the-art quality oncology care and new technology to minority-underserved populations in their own communities through participation in NCI-approved clinical trials; focus on prevention and control as methods for reducing cancer incidence, morbidity and mortality; expand our clinical trial menu to include Cancer Care Delivery Research though access to the Chicago Area Patient Centered Outcomes Research Network (CAPriCORN) data base which is supported by a large PCORI grant; and extend and promote research involvement and opportunities with emphasis on the particular needs of the community served, promoting outreach and education.